Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2739)
All Articles published online
|
Feb 14, 2005 (publication date) through May 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fu XH, Zhang JS, Zhang N, Zhang YD. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line. World J Gastroenterol 2005; 11(6): 785-790 [PMID: 15682468 DOI: 10.3748/wjg.v11.i6.785] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i6/785.htm |
| Number | Citing Articles |
| 1 |
Hei Cheul Jeung, Sun Young Rha, Sang Joon Shin, Joong Bae Ahn, Kyu Hyun Park, Tae Soo Kim, Jin Ju Kim, Jae Kyung Roh, Hyun Cheol Chung. Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer. Oncology Letters 2017; 14(2): 2385 doi: 10.3892/ol.2017.6438
|
| 2 |
Ji-yong Liu, Qiang Zhu, Jianfeng Li, Shulei Zhao, Luning Li. The Retrovirus-mediated Antisense Human Telomerase RNA (hTR) Gene Limits the Growth of Hepatocellular Carcinoma Growth in Cell Culture and Animals. Digestive Diseases and Sciences 2008; 53(4): 1122 doi: 10.1007/s10620-007-9980-4
|
| 3 |
Xue-mei JI, Cong-hua XIE, Ming-hao FANG, Fu-xiang ZHOU, Wen-jie ZHANG, Ming-sheng ZHANG, Yun-feng ZHOU. Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy. Acta Pharmacologica Sinica 2006; 27(9): 1185 doi: 10.1111/j.1745-7254.2006.00417.x
|
| 4 |
Shalini Bajaj, Maushmi S Kumar, GJ Peters, YC Mayur. Targeting telomerase for its advent in cancer therapeutics. Medicinal Research Reviews 2020; 40(5): 1871 doi: 10.1002/med.21674
|
| 5 |
Adam Eckburg, Joshua Dein, Joseph Berei, Zachary Schrank, Neelu Puri. Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy. Cancers 2020; 12(9): 2337 doi: 10.3390/cancers12092337
|
| 6 |
Simone Mocellin, Karen A. Pooley, Donato Nitti. Telomerase and the search for the end of cancer. Trends in Molecular Medicine 2013; 19(2): 125 doi: 10.1016/j.molmed.2012.11.006
|
| 7 |
Faiza Noreen, Jochen Heinrich, Karin Moelling. Antitumor Activity of Small Double-Stranded Oligodeoxynucleotides Targeting Telomerase RNA in Malignant Melanoma Cells. Oligonucleotides 2009; 19(2): 169 doi: 10.1089/oli.2008.0170
|
| 8 |
SunMi L. Palumbo, Scot W. Ebbinghaus, Laurence H. Hurley. Formation of a Unique End-to-End Stacked Pair of G-Quadruplexes in the hTERT Core Promoter with Implications for Inhibition of Telomerase by G-Quadruplex-Interactive Ligands. Journal of the American Chemical Society 2009; 131(31): 10878 doi: 10.1021/ja902281d
|
| 9 |
M. I. Zvereva, T. S. Zatsepin, D. M. Azhibek, O. S. Shubernetskaya, O. V. Shpanchenko, O. A. Dontsova. Oligonucleotide inhibitors of telomerase: Prospects for anticancer therapy and diagnostics. Biochemistry (Moscow) 2015; 80(3): 251 doi: 10.1134/S0006297915030013
|
| 10 |
Terace M Fletcher. Telomerase: a potential therapeutic target for cancer. Expert Opinion on Therapeutic Targets 2005; 9(3): 457 doi: 10.1517/14728222.9.3.457
|